Re: Step Therapy for Part B Drugs in Medicare Advantage
Dear Secretary Becerra,
The undersigned organizations, representing millions of Medicare beneficiaries with life-threatening, complex, chronic
conditions and the physicians who care for them, are asking the Centers for Medicare and Medicaid Services (CMS) to
ensure that beneficiaries enrolled in Medicare Advantage plans continue to have appropriate and timely access to the
therapies they need to properly manage their conditions. We write to you today regarding the implementation of
utilization management protocols and specifically the reinstatement of an important patient protection for beneficiaries
in Medicare Advantage (MA) plans.
Read full letter here
